Abstract
Hormones, particularly those produced by the gonads, and their synthetic analogs have been the subject of controversy concerning their roles in the process of carcinogenesis. Experimental evidence, dating from 1916 [118] (Table 1), that estrogens can be potent carcinogens was overlooked or lightly dismissed by many because of a prevalent belief that the body should be able to metabolize these physiologic compounds without toxic effects. The relevance of animal experiments to the human cancer problem was also questioned. During the past four decades, a variety of naturally occurring and synthetic estrogens, progestins, and androgens have been manufactured and prescribed in ever-increasing amounts for replacement, treatment of cancer, prevention of abortion, suppression of lactation, contraception, and other purposes without adequate attention to their carcinogenic potential.
I am indebted to Drs. Harold L. Stewart, Heramn F. Kraybill, and Erwun P. Vollmer for their helpful comments and suggestions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, N. R.: Pathological changes in the tissues of infertile ewes with clover disease. J. Comp. Pathol. 86, 29–35 (1976)
Adelman, R. C.: Impaired hormonal regulation of enzyme activity during aging. Fed. Proc. 34, 179–182 (1975)
Adlercreutz, H., Tenhunen, R.: Some aspects of the interaction between natural and synthetic female sex hormones and the liver. Am. J. Med. 49, 630–648 (1970)
Akazaki, K., Stemmermann, G. N.: Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J. Natl. Cancer Inst. 50, 1137–1144 (1973)
Apostolakis, M., Kapetanakis, S., Lazos, G., Madena-Pyrgaki, A.: Plasma prolactin activity in male and female patients lactating due to psychotropic drug administration. Acta Endocrinol. Suppl. 155, 19 (1971) (Abstract)
Arcos, J. C., Argus, M. F.: Chemical Induction of Cancer. Vol. IIA. New York and London: Academic Press, 1974a
Arcos, J. C., Argus, M. F.: Chemical Induction of Cancer. Vol. IIB. New York and London: Academic Press, 1974b
Armenian, H. K., Lilienfeld, A. M., Diamond, E. L., Bross, I. D. J.: Relation between benign prostatic hyperplasia and cancer of the prostate. Lancet 2, 115–117 (1974)
Armstrong, B., Stevens, N., Doll, R.: Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women. Lancet 2, 672–675 (1974)
Ashley, D. J. B.: A male-female differential in tumour incidence. Br. J. Cancer 23, 21–25 (1969)
Barraclough, C. A.: Blockade of the release of pituitary gonadotropin by reserpine. Fed. Proc. 14, 9–10 (1955)
Baum, J. K., Holtz, F., Bookstein, J. J., Klein, E. W.: Possible association between benign hepatomas and oral contraceptives. Lancet 2, 926–929 (1973)
Beatson, G. T.: On the treatment of inoperable cases of carcinoma of the mamma: Suggestion for a new method of treatment with illustrative cases. Lancet 2, 104–107 (1896)
Bern, H. A., Jones, L. A., Mills, K. T., Kohrman, A., Mori, T.: Use of the neonatal mouse in studying longterm effects of early exposure to hormones and other agents. J. Toxicol. Environ. Health Suppl. 1, 103–116 (1976)
Beumont, P. J. V., Harris, G. W., Carr, P. J., Friesen, H. G., Kolakowska, T., Mackinnon, P. C. B., Mandelbrote, B. M., Wiles, D.: Some endocrine effects of phenothiazines; a preliminary report. J. Psychosom. Res. 16, 297–304 (1972)
Bibbo, M., Gill, W. B., Azizi, F., Blough, R., Fang, V. S., Rosenfield, R. L., Schumacher, G. F. B., Sleeper, K., Sonek, M. G., Wied, G. L.: Follow-up study of male and female offspring of DES-exposed mothers. Obstet. Gynecol. 49, 1–8 (1977)
Bickoff, E. M., Booth, A. N., Lyman, R. L., Livingston, A. L., Thompson, C. R., Deeds, F.: Coumestrol, a new estrogen isolated from forage crops. Science 126, 969–970 (1957)
Bickoff, E. M., Livingston, A. L., Hendrickson, A. P., Booth, A. N.: Relative potencies of several estrogenlike compounds found in forages. J. Agric. Food Chem. 10, 410–412 (1962)
Bird, D. R., Vowles, K. D. J.: Liver damage from long term methyltestosterone. Lancet 2, 400–401 (1977)
Bitman, J., Cecil, H. C.: Estrogenic activity of DDT analogs and polychlorinated biphenyls. J. Agric. Food Chem. 18, 1108–1112 (1970)
Bolande, R. P.: Childhood tumors and their relationship to birth defects. In Genetics of Human Cancer. Mulvihill, J. J., Miller, R. W., Fraumeni, J. F., Jr. (Eds.). New York: Raven Press, 1977
Boston Collaborative Drug Program. Reserpine and breast cancer. Lancet 2, 669–671 (1974)
Bradbury, R. B., White, D. E.: Estrogens and related substances in plants. Vitam. Horm. 12, 207–233 (1954)
Brooks, S. C.: The metabolism of steroid hormones in breast cancer: A reappraisal. Curr. Top. Mol. Endocrinol. 4, 36–50 (1976)
Budzynska, A., Wasikowa, R., Zajac, J.: Hyperestrogenism in children of employees of the Polfa Pharmaceutical Laboratories in Jenenia Gora. Pol. Med. J. 6, 1249–1256 (1967)
Buell, P.: Changing incidence of breast cancer in Japanese-American women. J. Natl. Cancer Inst. 51, 1479–1483 (1973)
Buell, P., Dunn, J. E.: Cancer mortality among Japanese issei and nisei of California. Cancer 18, 656–664 (1965)
Burbank, F.: Patterns in Cancer Mortality in the United States: 1950–1967. Natl. Cancer Inst. Monogr. 33, 307 (1971)
Carcinogenicity Testing of Oral Contraceptives. Report by the Committee on Safety of Medicines. London: Her Majesty’s Stationery Office, 1972
Chen, H. J., Bradley, C. J., Meites, J.: Stimulation of growth of carcinogen-induced mammary cancers in rats by thyrotropin-releasing hormone. Cancer Res. 37, 64–66 (1977)
Chu, E. W., Salmon, M. J.: Observations on vaginal cornification in patients resident in a mental hospital. Am. J. Obstet. Gynecol. 83, 165–170 (1962)
Clemens, J. A., Smalstig, E. B., Sawyer, B. D.: Antipsychotic drugs stimulate prolactin release. Psychopharmacologia (Berl.) 40, 123–127 (1974)
Conney, A. H., Burns, J. J.: Metabolic interactions among environmental chemicals and drugs. Science 178, 576–586 (1972)
Corbett, D. G., Abrams, E. W.: Bilateral carcinoma of the male breast associated with prolonged stilbestrol therapy for carcinoma of the prostate. J. Urol. 64, 377–381 (1950)
Costlow, M. E., McGuire, W. L.: Autoradiographic localization of prolactin receptors in 7,12-dimethylbenz[a]anthracene-induced rat mammary carcinoma. J. Natl. Cancer Inst. 58, 1173–1175 (1977)
Cutler, B. S., Forbes, A. P., Ingersoll, F. M., Scully, R. E.: Endometrial carcinoma after stilbestrol therapy in gonadal dysgenesis. New Engl. J. Med. 287, 628–631 (1972)
Dao, T. L., Morreal, C., Nemoto, T.: Urinary estrogen excretion in men with breast cancer. New Engl. J. Med. 289, 138–140 (1973)
Dean, L., Abell, D. A., Beischer, N. A.: Incidence of anencephaly and other major malformations when oestriol excretion is very low. Br. Med. J. 1, 257–258 (1977)
Diczfalusy, E.: Recent progress in the fetoplacental metabolism of steroids. In: Reproductive Endocrinology. Vokaer, R., DeBock, G. (Eds.). New York: Pergamon Press, 1975, p. 3
Dodds, E. C., Golberg, L., Lawson, W., Robinson, R.: Oestrogenic activity of certain synthetic compounds. Nature (London) 141, 247–248 (1938)
Doisy, E. A., Veler, C. D., Thayer, S.: Folliculin from urine of pregnant women. Am. J. Physiol. 90, 329–330 (1929)
Dunn, J. E., Jr., Bragg, K. U., Sautter, C., Gardipee, C.: Breast cancer risk following a major salivary gland carcinoma. Cancer 29, 1343–1346 (1972)
Dunn, T. B.: Cancer of the uterine cervix in mice fed a liquid diet containing an antifertility drug. J. Natl. Cancer Inst. 43, 671–692 (1969)
Dunn, T. B., Green, A. W.: Cysts of the epididymis, cancer of the cervix, granular cell myoblastoma, and other lesions after estrogen injection in newborn mice. J. Natl. Cancer Inst. 31, 425–455 (1963)
Edgren, R. A.: Are oral contraceptives and diethylstilbestrol (DES) involved in sex-linked cancer? Curr. Top. Mol. Endocrinol. 4, 95–106 (1976)
Editorial: Cyproterone acetate. Lancet 1, 1003–1004 (1976)
Edmondson, H. A.: Tumors of the Gallbladder and Extrahepatic Bile Ducts. In: Atlas of Tumor Pathology, Section VII, Fascicle 26. Washington, D.C.: Armed Forces Inst. Pathol., 1967
Eideisberg, J.: Estrogens in urine and cytology of vaginal smears after the use of an estrogenic cream. Am. J. Med. Sci. 214, 630–632 (1947)
Eisenfeld, A. J., Aten, R., Weinberger, M., Haselbacher, G., Halpern, K., Krakoff, L.: Estrogen receptor in the mammalian liver. Science 191, 862–865 (1976)
Everson, R. B., Li, F. P., Fraumeni, J. F., Jr., Fishman, J., Wilson, R. E., Stout, D., Norris, H. J.: Familial male breast cancer. Lancet 1, 9–12 (1976)
Faber, L. E., Saffran, J., Chen, T. J., Leavitt, W. W.: Mammalian progesterone receptors: Biosynthesis, structure and nuclear binding. Curr. Top. Mol. Endocrinol. 4, 68–84 (1976)
Farrell, G. C., Joshua, D. E., Uren, R. F., Baird, P. J., Perkins, K. W., Kronerberg, H.: Androgen-induced hepatoma. Lancet 1, 430–432 (1975)
Fechner, R. E.: Carcinoma of the breast during estrogen replacement therapy. Cancer 29, 566–573 (1972)
Fechner, R. E.: Influence of oral contraceptives on breast diseases. Cancer 39, 2764–2771 (1977)
Festing, M., Staats, J.: Standardized nomenclature for inbred strains of rats. Transplantation 16, 221–245 (1973)
Fitzsimons, M. P.: Gynaecomastia in stilboestrol workers. Br. J. Ind. Med. 1, 235–237 (1945)
Forsberg, J.-G.: Derivation and differentiation of the vaginal epithelium. Lund, The Institute of Anatomy (Thesis), 1963
Forsberg, J.-G.: Induction of conditions leading to cancer in the genital tract by estrogen during the differentiation phase of the genital epithelium. Adv. Biosci. 13, 139–151 (1974)
Forsberg, J.-G.: Animal model: Estrogen-induced adenosis of vagina and cervix in mice. Am. J. Pathol. 84, 669–672 (1976)
Fotherby, K.: Metabolism of synthetic steroids by animals and man. Acta Endocrinol. Suppl. 185, 119–147 (1974)
Foulds, L.: Neoplastic Development, Vol. 2. New York: Academic Press, 1975
Fraumeni, J. F., Lloyd, J. W., Smith, E. M., Wagoner, J. K.: Cancer mortality among nuns: Role of marital status in etiology of neoplastic disease in women. J. Natl. Cancer Inst. 42, 455–468 (1969)
Furth, J.: Recent experimental studies on leukosis. Physiol. Rev. 26, 47–76 (1946)
Gardner, W. U., Allen, E.: Malignant and non-malignant uterine and vaginal lesions in mice receiving estrogens and estrogens and androgens simultaneously. Yale J. Biol. Med. 12, 213–234 (1939)
Gardner, W. U., Pan, S. C.: Malignant tumors of the uterus and vagina in untreated mice of the PM stock. Cancer Res. 8, 241–256 (1948)
Gardner, W. U., Dougherty, T. F., Williams, W. L.: Lymphoid tumors in mice receiving steroid hormones. Cancer Res. 4, 73–87 (1944)
Gaunt, R., Renzi, A. A., Antonchak, N., Miller, G. J., Gilman, M.: Endocrine aspects of the pharmacology of reserpine. Ann. N.Y. Acad. Sci. 59, 22–35 (1954)
Gillette, J. R., Stripp, B.: Pre- and postnatal enzyme capacity for drug metabolite production. Fed. Proc. 34, 172–178 (1975)
Grandison, L., Guidotti, A.: Regulation of prolactin release by endogenous opiates. Nature (London) 270, 357–359 (1977)
Greenblatt, D.J., Koch-Weser, J.: Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program. J. Am. Med. Assoc. 225, 40–43 (1973)
Greenblatt, R. B., Brown, N. H.: The storage of estrogen in human fat after estrogen administration. Am. J. Obstet. Gynecol. 63, 1361–1363 (1952)
Greene, H. S. N.: Diseases of the rabbit. In: Pathology of Laboratory Animals. Ribelin, W. E., McCoy, J. R. (Eds.). Springfield: Charles C. Thomas, 1965, p. 330
Grumbach, M. M.: Gonads. Sex determination and sex differentiation. In: Textbook of Medicine. Beeson, P.B., McDermott, W. (Eds.). Philadelphia and London: W. B. Saunders Co., 1963, p. 1407
Gupta, R. L.: Carcinoma of the breast in a case of Klinefelter syndrome. Indian J. Cancer 3, 184–189 (1966)
Gustafsson, J., Stenberg, A.: Partial masculinization of rat liver enzyme activities following treatment with FSH. Endocrinology 96, 501–504 (1975)
Hadler, H. I.: Reserpine and chemical carcinogenesis. Lancet 1, 169 (1975)
Haenszel, W., Kurihara, M.: Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J. Natl. Cancer Inst. 40, 43–68 (1968)
Harmon, J., Aliapoulios, M. A.: Gynecomastia in marijuana users. New Engl. J. Med. 287, 936 (1972)
Harry, R. G.: Modern Cosmetology, Vol. 1. New York: Chemical Publishing Co., 1968
Harwig, J., Munro, I. C.: Mycotoxins of possible importance in diseases of Canadian farm animals. Can. Vet. J. 16, 125–139 (1975)
Hausknecht, R. U., Gusberg, S. B.: Estrogen metabolism in patients at high risk for endometrial carcinoma. Am. J. Obstet. Gynecol. 116, 981–984 (1973)
Heath, E. C., Dingell, J. V.: The interaction of foreign chemical compounds with the glucuronidation of estrogens in vitro. Drug Metab. Dispos. 2, 556–565 (1974)
Heinonen, O. P., Shapiro, S., Tuonimen, L., Turunen, M. I.: Reserpine use in relation to breast cancer. Lancet 2, 675–677 (1974)
Heinonen, O. P., Slone, D., Monson, R. R., Hook, E. B., Shapiro, S.: Cardiovascular birth defects and antenatal exposure to female sex hormones. New Engl. J. Med. 296, 67–70 (1977)
Helton, E. D., Goldzieher, J. W.: The pharmacokinetics of ethynyl estrogens. A review. Contraception 15, 255–284 (1977)
Henderson, B. E., Gerkins, V. R., Pike, M. C.: Sexual factors and pregnancy. In: Persons at High Risk of Cancer. Fraumeni, J. F. (Ed.). New York: Academic Press, Inc., 1975, p. 267
Herbst, A. L., Ulfelder, H., Poskanzer, D. C.: Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. New Engl. J. Med. 284, 878–881 (1971)
Hertig, A. T., Gore, H.: Tumors of the female sex organs. Part 2. Tumors of the vulva, vagina and uterus. In: Atlas of Tumor Pathology, Section IX, Fascicle 33. Washington, D.C.: Armed Forces Inst. of Pathol., 1960
Hertz, R.: Steroid-induced, steroid-producing, and steroid-responsive tumors. Curr. Top. Mol. Endocrinol. 4, 1–14 (1976)
Heston, W. E., Vlahakis, G., Desmukes, B.: Effects of the antifertility drug Enovid in five strains of mice, with particular regard to carcinogenesis. J. Natl. Cancer Inst. 51, 209–224 (1973)
Hill, M. J., Goddard, P., Williams, R. E. O.: Gut bacteria and etiology of cancer of the breast. Lancet 2, 472–473 (1971)
Hoover, R., Fraumeni, J. F., Jr., Everson, R., Myers, M. H.: Cancer of the uterine corpus after hormonal treatment for breast cancer. Lancet 1, 885–887 (1976)
Hoover, R., Gray, L. A., Cole, P., MacMahon, B.: Menopausal estrogens and breast cancer. New Engl. J. Med. 295, 401–405 (1976)
Hoover, R., Gray, L. A., Sr., Fraumeni, J. F.: Stilboestrol (diethylstilboestrol) and the risk of ovarian cancer. Lancet 2, 533–534 (1977)
Huseby, R. A.: Estrogen-induced Leydig cell tumor in the mouse: A model system for the study of carcinogenesis and hormone dependency. J. Toxicol. Environ. Health, Suppl. 1, 177–192 (1976)
Ingelfinger, F. J.: Gallstones and estrogens. New Engl. J. Med. 290, 51–52 (1974)
International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. Sex Hormones, Vol. 6. Lyon: International Agency for Research on Cancer, 1974
International Agency for Research on Cancer, World Health Organization. Cancer Incidence in Five Continents, Vol. III. Waterhouse, J., Muir, C., Correa, P., Powell, J. (Eds.). IARC Scientific Publications No. 15. Lyon: International Agency for Research on Cancer, 1976
Jackson, A. W., Muldal, S., Ockey, C. H., O’Connor, P. J.: Carcinoma of male breast in association with the Klinefelter syndrome. Br. Med. J. 1, 223–225 (1965)
Jasmin, G., Riopelle, J. L.: Nephroblastomas induced in ovariectomized rats by dimethylbenzanthracene. Cancer Res. 30, 321–326 (1970)
Joly, D., Lilienfeld, A. J., Diamond, E. L., Bross, I. D.: An epidemiologic study of the relationship of reproductive experience with cancer of the ovary. Am. J. Epidemiol. 99, 190–209 (1974)
Jones, L. A., Bern, H. A.: Long-term effects of neonatal treatment with progesterone, alone and in combination with estrogen, on the mammary gland and reproductive tract of female BALB/cfC3H mice. Cancer Res. 37, 67–75 (1977)
Jørgensen, P. I.: Low urinary oestriol excretion during pregnancy in women giving birth to infants with Down’s syndrome. Lancet 2, 782–783 (1972)
Kaplan, N. M.: Male pseudohermaphrodism. Report of a case with observations on pathogenesis. New Engl. J. Med. 261, 641–644 (1959)
Kimura, T., Nandi, S.: Nature of induced persistent vaginal cornification in mice. IV. Changes in the vaginal epithelium of old mice treated neonatally with estradiol or testosterone. J. Natl. Cancer Inst. 39, 75–93 (1967)
King, N. W.: Comparative pathology of the uterus. In: The Uterus. Norris, H. J., Hertig, A. T., Abel, M. R. (Eds.). Baltimore: Williams and Wilkins, 1973, p. 489
Kirschner, M. A.: The role of hormones in the etiology of human breast cancer. Cancer 39, 2716–2726 (1977)
Kling, R. E., Lazar, A.: The development of a radioimmunometric assay for diethylstilbestrol in tissues: Part I. FDA By-Lines, No. 2, September 1976, p. 65
Kodama, M., Kodama, T., Totani, R.: Hormonal status of cervical cancer. J. Natl. Cancer Inst. 59, 41–47 (1977)
Koo, G. C., Wachtel, S. S., Saenger, P., New, M. I., Dosik, H., Amarose, A. P., Dorus, E., Ventruto, V.: H-Y Antigen: Expression in human subjects with the testicular feminization syndrome. Science 196, 655–656 (1977)
Koss, L. G.: Diagnostic Cytology and its Histopathologic Bases. Philadelphia: Lippincott, 1968
Kupfer, D., Bulger, W. H.: Interactions of chlorinated hydrocarbons with steroid hormones. Fed. Proc. 35, 2603–2608 (1976)
Lacassagne, A.: Sarcomes lymphoides apparus chez des souris longuement traitées par des hormones oestrogenes. C.R. Soc. Biol. Paris 126, 193–195 (1937)
Lacassagne, A.: Effets opposés de l’iproniazide et de la resérpine, sur la cancérisation du foie du rat par p-dimethylaminoazobenzene. C.R. Acad. Sci. Paris 263, 701–703 (series D) (1966)
Lacassagne, A., Duplan, J.-F.: Le mécanisme de la cancérisation de la mamelle chez la souris, consideré d’apres les résultats d’experiences au moyen de la reserpine. Compt. Rend. 249, 810–812 (1959)
Lacassagne, A., Hurst, L., Rosenberg, A.-J.: Influence de la chlorpromazine et de la reserpine sur la cancerisation experimentale du foie chez le rat. Compt. Rend. 249, 903–905 (1959)
Lacassagne, M. A.: Apparition de cancers de la mamelle chez la souris mâle, soumise à des injections de folliculine. Compt. Rend. Acad. Sci. 195, 630–632 (1932)
Lathrop, A. E. C., Loeb, L.: Further investigations on the origin of tumors in mice. III. On the part played by internal secretion in the spontaneous development of tumors. J. Cancer Res. 1, 1–19 (1916)
Leonard, B. J.: The use of rodents for studies of toxicity in contraceptive research. Acta Endocrinol. Suppl. 185, 34–73 (1974)
Leopold, A. S., Erwin, M., Oh, J., Browning, B.: Phytoestrogens: Adverse effects on reproduction in California quail. Science 191, 98–100 (1976)
LeWinn, E. B.: Gynecomastia during digitalis therapy. New Engl. J. Med. 248, 316–320 (1953)
Lewis, R. M.: The clinical use of stilbestrol, a synthetic estrogen. Preliminary report. Yale J. Biol. Med. 12, 235–238 (1939)
Liao, S., Hung, S. C., Tymoczko, J. L., Liang, T.: Active forms and biodynamics of the androgen-receptor in various target tissues. Curr. Top. Mol. Endocrinol. 4, 139–151 (1976)
Licata, A. A., Bartter, F. C.: Spironolactone-induced gynaecomastia related to allergic reaction to ‘Darvon compound’. Lancet 2, 905 (1976)
Lilienfeld, A. M.: Possible existence or predisposing factors in the etiology of selected cancers of non-sexual sites in females: A preliminary inquiry. Cancer 9, 111–122 (1956)
Lingeman, C. H.: Liver-cell neoplasms and oral contraceptives. Lancet 1, 64 (1974a)
Lingeman, C. H.: Etiology of cancer of the ovary: A review. J. Natl. Cancer Inst. 53, 1603–1618 (1974b)
Lippman, M., Barr, R.: Glucocorticoid receptors in purified subpopulations of human peripheral blood lymphocytes. J. Immunol. 118, 1977–1981 (1977)
Lippman, M. E., Osborne, C. K., Knazek, R., Young, N.: In vitro model systems for the study at hormone-dependent human breast cancer. New Engl. J. Med. 296, 154–159 (1977)
Loube, S. D., Quirk, R. A.: Breast cancer associated with administration of spironolactone. Lancet 1, 1428–1429 (1975)
Lyon, F. A.: Development of adenocarcinoma of endometrium in young women receiving long-term sequential oral contraception. Am. J. Obstet. Gynecol. 123, 299–301 (1975)
Mack, T. M., Henderson, B. E., Gerkins, V. R., Arthur, M., Baptista, J., Pike, M. C.: Reserpine and breast cancer in a retirement community. New Engl. J. Med. 292, 1366–1371 (1975)
MacMahon, B., Austin, J. H.: Association of carcinomas of breast and corpus uteri. Cancer 23, 275–280 (1969)
MacMahon, B., Cole, P., Brown, J.: Etiology of human breast cancer: A review. J. Natl. Cancer Inst. 50, 21–42 (1973)
Mainwaring, W. I. P.: The relevance of studies on androgen action to prostatic cancer. Curr. Top. Mol. Endocrinol. 4, 152–171 (1976)
McCarty, K. S., Jr., McCarty, K. S.: Steroid hormone receptors in the regulation of differentiation. A review. Am. J. Pathol. 86, 703–744 (1977)
McGuire, W. L., Horwitz, K. B., Pearson, O. H., Segaloff, A.: Current status of estrogen and progesterone receptors in breast cancer. Cancer 39, 2934–2947 (1977)
McKinney, G. R., Weikel, J. H., Webb, W. K., Dick, R. G.: Use of life-table techniques to estimate effects of certain steroids on probability of tumor formation in a long term study in rats. Toxicol. Appl. Pharmacol. 12, 68–79 (1968)
McLachlan, J. A.: Transplacental toxicity of diethylstilbestrol: A special problem in safety evaluation. Adv. Modern Toxicol. 1, 423–448 (1976)
McLachlan, J. A., Newbold, R. R., Bullock, B.: Reproductive tract lesions in male mice exposed prenatally to diethylstilbestrol. Science 190, 991–992 (1975)
McLean, A. E. M.: Enzyme induction in the fetus and the role of enzyme induction in the localization of carcinogenesis. In: Transplacental Carcinogenesis. Tomatis, L., Mohr, U. (Eds.). Lyon: International Agency for Research on Cancer, 1973
Meissner, W. A., Sommers, S. C., Sherman, G.: Endometrial hyperplasia, endometrial carcinoma and endometriosis produced experimentally by estrogen. Cancer 10, 500–509 (1957)
Meltzer, H. Y., Sachar, E. J., Frantz, A. G.: Dopamine antagonism by thioridazine in schizophrenia. Biol. Psychiatry 10, 53–57 (1975)
The Merck Index, 9th Ed., Windholz, M. (Ed.). Rahway: Merck and Co., 1976
Migaki, G., Carey, A. M., Turnquest, R. U., Garner, F. M.: Pathology of bovine uterine adenocarcinoma. J. Am. Vet. Med. Assoc. 157, 1577–1584 (1970)
Mirocha, C. J., Christensen, C. M., Nelson, G. H.: Physiologic activity of some fungal estrogens produced by Fusarium. Cancer Res. 28, 2319–2322 (1968)
Moore, C. R., Lamar, J. K., Beck, N.: Cutaneous absorption of sex hormones. J. Am. Med. Assoc. 111, 11–14 (1938)
Mostofi, F. K., Leestma, J. E.: Lower urinary tract and male genitalia. In: Pathology, sixth edition, Vol. 1. Anderson, W. A. D. (Ed.). St. Louis: C.V. Mosby, 1971, p. 828
Mostofi, F. K., Price, E. B: Tumors of the male genital system. In: Atlas of Tumor Pathology, second series, Fascicle 8. Washington, D.C.: Armed Forces Inst. Pathol., 1973
Mulvihill, J. J.: Congenital and genetic diseases. In: Persons at High Risk of Cancer. Fraumeni, J. F. (Ed.). New York: Academic Press, 1975, p. 3
Murphy, E. D.: Carcinogenesis of the uterine cervix in mice. Effect of diethylstilbesterol after limited application of 3-methylcholanthrene. J. Natl. Cancer Inst. 27, 611–653 (1961)
Murphy, E. D.: Carcinogenesis of the uterine cervix in mice: Effect of castration after limited application of 3-methylcholanthrene. J. Natl. Cancer Inst. 41, 1111–1116 (1968)
Nadell, J., Kosek, J.: Peliosis hepatis. Twelve cases associated with oral androgen therapy. Arch. Pathol. Lab. Med. 101, 405–410 (1977)
Nelson, G. H., Christensen, C. M., Mirocha, C.: Fusarium and estrogenism in swine. J. Am. Vet. Med. Assoc. 163, 1276–1277 (1973)
Neumann, F., Graf, K. J.: Discovery, development, mode of action and clinical uses of cyproterone acetate. J. Int. Med. Res. 3 (Suppl. 4), 1–9 (1975)
Nicolis, G. L., Sabetghadam, R., Hsu, C. C. S., Sohval, A. R., Gabrilove, J. L.: Breast cancer after mumps orchitis. J. Am. Med. Assoc. 223, 1032–1033 (1973)
Noble, R. L.: The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res. 37, 1929–1933 (1957)
Noble, R. L.: A new approach to the hormonal cause and control of experimental carcinomas, including those of the breast. Ann. R. Coll. Phys. Surg. Can. 9, 169–180 (1976)
Noble, R. L.: Hormonal control of growth and progression in tumors of Nb rats and a theory of action. Cancer Res. 37, 82–94 (1977)
Nomura, T., Kanzaki, T.: Induction of urogenital anomalies and some tumors in the progeny of mice receiving diethylstilbestrol during pregnancy. Cancer Res. 37, 1099–1104 (1977)
Nomura, Y., Kobayashi, S., Takatani, O., Sugano, H., Matsumoto, K., McGuire, W. L.: Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients. Cancer Res. 37, 106–110 (1977)
Norris, H. J., Taylor, H. B.: Carcinoma of the male breast. Cancer 23, 1428–1435 (1969)
O’Fallon, W. M., Labarthe, D. R., Kurland, L. T.: Rauwolfia derivatives and breast cancer. Lancet 2, 292–300 (1975)
O’Shea, J. D., Jabara, A. G.: The histogenesis of canine ovarian tumours induced by stilboestrol administration. Pathol. Vet. 4, 137–148 (1967)
Otten, J., Smets, R., Jager, R. de, Gerard, A., Maurus, R.: Hepatoblastoma in an infant after contraceptive intake during pregnancy. New Engl. J. Med. 297, 222 (1977)
Overholser, M. D., Allen, E.: Atypical growth induced in cervical epithelium of the monkey by prolonged injection of ovarian hormone combined with chronic trauma. Surg. Gynecol. Obstet. 60, 129–136 (1935)
Persijn, R. P., Korsten, C. B., Engelsman, E.: Oestrogen and androgen receptors in breast cancer. Br. Med. J. 4, 503 (1975)
Petit, P., Engels, J.: Low maternal oestriol excretion and congenital chromosome abnormalities. Lancet 2, 970 (1972)
Physicians Desk Reference, 31st Edition. Oradell, N. J., Medical Economics Co., 1977
Pollard, M., Luckert, P. H.: Transplantable metastasizing prostate adenocarcinomas in rats. J. Natl. Cancer Inst. 54, 643–649 (1975)
Poortman, J., Prenan, J. A. C., Schwarz, F., Thijssen, J. H. H.: Interaction of Δ5-androstene-3β, 17β-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue. J. Clin. Endocrinol. Metab. 40, 373–379 (1975)
Pryor, A. C., Cohen, R. J., Goldman, R. L.: Hepatocellular carcinoma in a woman on long term oral contraceptives. Cancer 40, 884–888 (1977)
Rogers, P. C., Komp, D., Rogol, A., Sabio, H.: Possible effects of growth hormone on development of acute lymphoblastic leukaemia. Lancet 2, 434–435 (1977)
Rudali, G., Apiou, F., Muel, B.: Mammary cancer produced in mice with estriol. Eur. J. Cancer 11, 39–41 (1975)
Russfield, A. B.: Tumors of Endocrine Glands and Secondary Sex Organs. Washington, D.C.: USPHS, Department HEW, 1966
Rustia, M., Shubik, P.: Transplacental effects of diethylstilbestrol on the genital tract of hamster offspring. Cancer Lett. 1, 139–146 (1976)
Schaffer, A. J., Avery, M. E.: Diseases of the Newborn. Third Edition. Philadelphia: Saunders, 1971
Schardein, J. L., Kaump, D. H., Woosley, E. T., Jellema, M. M.: Long-term toxicologic and tumorigenesis studies on an oral contraceptive agent in albino rats. Toxicol. Appl. Pharmacol. 16, 10–23 (1970)
Scheike, O.: Male breast cancer. Acta Pathol. Microbiol. Scand., Section A, Suppl. 251, 13–35 (1975)
Schindler, A. E.: Steroid metabolism of fetal tissues. II. Conversion of androstenedione to estrone. Am. J. Obstet. Gynecol. 123, 265–268 (1975)
Schneider, S. L., Alks, V., Morreal, C. E., Sinha, D. K., Dao, T. L.: Estrogenic properties of 3,9-dihydroxybenz[a]anthracene, a potential metabolite of benz[a]anthracene. J. Natl. Cancer Inst. 57, 1351–1354 (1976)
Schoenberg, B. S., Christine, B. W., Whisnant, J. P.: Nervous system neoplasms and primary malignancies of other sites. Neurology 25, 705–712 (1975)
Schoenberg, B. S., Greenberg, R. A., Eisenberg, H.: Occurrence of certain multiple primary cancers in females. J. Natl. Cancer Inst. 43, 5–32 (1969)
Schoental, R.: Carcinogenic hazards of estrogens. In: Multiple Primary Malignant Tumours. Severi, L. (Ed.). Perugia: Division of Cancer Research, 1974, p. 1003
Shain, S. A., McCullough, B., Segaloff, A.: Spontaneous adenocarcinoma of the ventral prostate of aged A X C rats. J. Natl. Cancer Inst. 55, 177–180 (1975)
Shimkin, M. B., Grady, H. G.: Toxic and carcinogen effects of stilbestrol in strain C3H male mice. J. Natl. Cancer Inst. 2, 55–60 (1941)
Shimkin, M. B., Grady, H. G., Andervont, H. B.: Induction of testicular tumors and other effects of stilbestrol-cholesterol pellets in strain C mice. J. Natl. Cancer Inst. 2, 65–80 (1941)
Silverberg, S. G., Makowski, E. L.: Endometrial carcinoma in young women taking oral contraceptive agents. Obstet. Gynecol. 46, 503–506 (1975)
Smith, D. C., Prentice, R., Thompson, D. J., Herrmann, W. L.: Association of exogenous estrogen and endometrial carcinoma. New Engl. J. Med. 293, 1164–1167 (1975)
Smith, O. W., Smith, G. V. S., Hurwitz, D.: Increased excretion of pregnanediol in pregnancy from diethylstilbestrol with special reference to the prevention of late pregnancy accidents. Am. J. Obstet. Gynecol. 51, 411–415 (1946)
Smith, R. L.: Biliary excretion and hepatotoxicity of contraceptive steroids. Acta Endocrinol. Suppl. 185, 149–168 (1974)
Smithline, F., Sherman, L., Kolodny, H. D.: Prolactin and breast carcinoma. New Engl. J. Med. 292, 784–792 (1975)
Snell, K. C.: Spontaneous lesion of the rat. In: Pathology of Laboratory Animals. Ribelin, W. E., McCoy, J. R. (Eds.). Springfield: Charles C. Thomas, 1965, p. 266
Song, C. S., Kappas, A.: The influence of hormones on hepatic function. In: Progress in Liver Diseases, 1971, Vol. 3, p. 89
Stangel, J. J., Innerfield, I., Reyniak, J. U., Stone, M. L.: The effect of conjugated estrogens on coagulability in menopausal women. Obstet. Gynecol. 49, 314–316 (1977)
Stumpf, W. E., Sar, M., Aumüller, G.: The heart: A target organ for estradiol. Science 196, 319–321 (1977)
Suntzeff, V., Burns, E. L., Moskop, M., Loeb, L.: On the proliferative changes taking place in the epithelium of vagina and cervix of mice with advancing age and under influence of experimentally administered estrogenic hormones. Am. J. Cancer 32, 256–289 (1938)
Sweeney, E. C., Evans, D. J.: Hepatic lesions in patients treated with synthetic anabolic steroids. J. Clin. Pathol. 29, 626–633 (1976)
Symmers, W. St. C.: Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics. Br. Med. J. 2, 83–85 (1968)
Tausk, M.: Pharmacology of Hormones. Stuttgart: Georg Thieme Publishers, 1975
Thomas, B. L.: Methadone-associated gynecomastia. New Engl. J. Med. 294, 169 (1976)
Thompson, E. B.: The cellular actions of glucocorticoids in relation to human neoplasms. Curr. Top. Mol. Endocrinol. 4, 114–132 (1976)
Tormey, D. C., Waalkes, T. P., Simon, R. M.: Biological markers in breast cancer. II. Clinical correlations with human chorionic gonadotropin. Cancer 39, 2391–2396 (1977)
Veterans Administration Cooperative Urologic Research Group: Treatment and survival of patients with cancer of the prostate. Surg. Gynecol. Obstet. 124, 1011–1017 (1967)
Vischer, E., Wittstein, A.: Enzymic transformation of steroids by microorganisms. In: Advances in Enzymology and Related Subjects of Biochem. New York: Interscience 1958, Vol. XX, p. 237
Wade, N.: Anabolic steroids: Doctors denounce them, but athletes are not listening. Science 176, 1399–1403 (1972)
Watrous, R. M., Olsen, R. T.: Diethylstilbestrol in industry: A test for early detection as an aid in prevention. Am. Ind. Hyg. Assoc. J. 20, 469–472 (1959)
Wilson, J. D.: Recent studies on the mechanism of action of testosterone. New Engl. J. Med. 287, 1284–1291 (1972)
World Health Organization Information Bulletin on the Survey of Chemicals Being Tested for Carcinogenicity. No. 7. Lyon: IARC, 1978
Wynder, E. L., Mabuchi, K., Whitmore, W. F.: Epidemiology of cancer of the prostate. Cancer 28, 344–360 (1971)
Zackheim, H. S.: Effect of castration of the induction of epidermal neoplasms in male mice by topical methylcholanthrene. J. Invest. Dermatol. 59, 479–482 (1970)
Ziel, H. K., Finkle, W. D.: Increased risk of endometrial carcinoma among users of conjugated estrogens. New Engl. J. Med. 293, 1167–1170 (1975)
Zumoff, B., Fishman, J., Cassouto, J., Hellman, L., Gallagher, T. F.: Estradiol transformation in men with breast cancer. J. Clin. Endocrinol. 26, 960–966 (1966)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Lingeman, C.H. (1979). Hormones and Hormonomimetic Compounds in the Etiology of Cancer. In: Lingeman, C.H. (eds) Carcinogenic Hormones. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 66. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81267-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-81267-5_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-08995-7
Online ISBN: 978-3-642-81267-5
eBook Packages: Springer Book Archive